Literature DB >> 3398236

Increased mortality of diabetics after acute myocardial infarction attributed to diffusely impaired left ventricular performance as assessed by echocardiography.

G Kouvaras1, D Cokkinos, M Spyropoulou.   

Abstract

Five hundred and forty-eight patients who sustained their first acute myocardial infarction (AMI) were admitted to the coronary care unit (CCU). Ninety-eight of them were known diabetics. The diabetic patients were younger, 50 +/- 12 vs. 64 +/- 18 years of age (p less than 0.05), and the proportion of females in their group was higher than in the nondiabetics, 44% vs. 33.4% (p less than 0.05). The in hospital mortality rate was 30% for diabetics and 16% for nondiabetics (p less than 0.001). Diabetics had a higher percentage of mortality caused by left ventricular failure (LVF) (p less than 0.025) and a tendency for more frequent complete A-V block (p less than 0.01) compared to nondiabetics. Obesity and a positive family history for coronary heart disease were more prevalent in the diabetic group (both p less than 0.01). The echocardiographic assessment of left ventricular function, performed in 125 consecutively admitted patients (25 diabetics and 100 nondiabetics) on the 3rd-5th post-infarct day, showed that the indices of myocardial contractility, that is, E point septal separation (EPSS), ejection fraction (EF) and fractional shortening (FS) were far more impaired in diabetics than in nondiabetics (p less than 0.01, p less than 0.005, p less than 0.005, respectively). No significant difference was found in the prevalence of dyskinetic, akinetic and hypokinetic segments between the two categories of patients, suggesting no difference in the amount of myocardial mass affected by the AMI. Our results indicate that the increased incidence of LVF developed in diabetics after an AMI compared to nondiabetics may be caused by other factors, probably some form of latent diabetic cardiomyopathy as a result of either small vessel disease or metabolic disorder.

Entities:  

Mesh:

Year:  1988        PMID: 3398236     DOI: 10.1536/ihj.29.1

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  7 in total

1.  Presentation, management, and outcomes of diabetic patients compared to non-diabetic patients admitted for acute coronary syndromes.

Authors:  T S Fergus; R Fazel; J Fang; S Chetcuti; D E Smith; E Kline-Rogers; K Munir; K A Eagle; D Mukherjee
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes.

Authors:  R Fazel; J Fang; E Kline-Rogers; D E Smith; K A Eagle; D Mukherjee
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 3.  Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.

Authors:  P Camacho; S Pitale; C Abraira
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

Review 4.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

Review 5.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

6.  Predictors of long-term survival in acute coronary syndrome patients with left ventricular dysfunction after percutaneous coronary intervention.

Authors:  Doo Hwan Lee; Myung Ho Jeong; Jung Ae Rhee; Jin Su Choi; Ki Hong Lee; Min Goo Lee; Doo Sun Sim; Keun-Ho Park; Nam Sik Yoon; Hyun Ju Yoon; Kye Hun Kim; Hyung Wook Park; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2012-10-31       Impact factor: 3.243

7.  NIAMI: Towards the optimization of results in primary PCI.

Authors:  Abdurrazzak Gehani; Jassim Al-Suwaidi; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.